A phase II trial of bevacizumab in patients with recurrent solid tumor brain metastases who have failed whole brain radiation therapy (WBRT).

Authors
Category Primary study
JournalJOURNAL OF CLINICAL ONCOLOGY
Year 2019
This article has no abstract
Epistemonikos ID: fa06cd0145d08a5d1f25c26acd1a4f03612f4b6a
First added on: Feb 11, 2025